Honeywell International Inc. (HON) reported an 8% increase in sales to $10.9 billion during the second quarter of 2018. Sales grew 6% on an organic basis, driven by widespread growth across the business.
Net income attributable to Honeywell decreased to $1.26 billion or $1.68 per share from $1.39 billion or $1.80 per share last year. Reported EPS declined 7%. On an adjusted basis, EPS grew 18% to $2.12, exceeding the high end of the company’s guidance range. The firm’s revenue and adjusted EPS numbers beat analyst expectations.
Operating income margin improved 40 basis points to 16.3%. Segment margin improved 60 basis points to 19.6%, coming in above the high end of the outlook provided last quarter.
Aerospace sales grew 8% on an organic basis driven by growth in business aviation OE, demand in commercial aftermarket and Transportation Systems along with strength in defense. Home and Building Technologies sales rose 3% organically helped by strength in residential thermal products and growth in the ADI distribution business.
Honeywell expects to complete the spinoff of its Transportation Systems operations by the end of the third quarter, at which time the business will be rebranded as Garrett. The Homes business spinoff is on track to be completed by the end of 2018. The company’s long-cycle orders and backlog grew 11% and 14% respectively.
Honeywell raised its guidance for full-year 2018. The company expects sales of $43.1 billion to $43.6 billion and organic growth of 5% to 6%. EPS is expected to grow 13% to 15% to a range between $8.05 and $8.15.
Related: Earnings preview: Honeywell might prevail despite the tariff war
Related: Honeywell International Inc. Q2 2018 Earnings Call Transcript
Related: Honeywell Q1 2018 Earnings Infographic
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company